Molecular Characterization of a First-in-Human Clinical Response to Nimesulide in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a hematologic malignancy associated with high morbidity and mortality. Here we describe a case of a patient with AML who presented a partial response after utilization of the non-steroidal anti-inflammatory drug nimesulide. The response was characterized by complete c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomaz, Victória, Griesi-Oliveira, Karina, Puga, Renato D., Conti, Bruno J., Santos, Fabio P. S., Hamerschlak, Nelson, Campregher, Paulo V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215211/
https://www.ncbi.nlm.nih.gov/pubmed/35756679
http://dx.doi.org/10.3389/fonc.2022.874168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215211/
https://www.ncbi.nlm.nih.gov/pubmed/35756679
http://dx.doi.org/10.3389/fonc.2022.874168

Ejemplares similares